{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T11:09:36Z","timestamp":1762513776079,"version":"build-2065373602"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T00:00:00Z","timestamp":1566345600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Center for Cell Reprogramming at GUMC"},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Papillomavirus Research"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.pvr.2019.100181","type":"journal-article","created":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T12:04:48Z","timestamp":1566475488000},"page":"100181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["High-throughput screening identifies candidate drugs for the treatment of recurrent respiratory papillomatosis"],"prefix":"10.1016","volume":"8","author":[{"given":"Faris","family":"Alkhilaiwi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siddartha","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feibai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Palechor-Ceron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelli","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajarshi","family":"Guha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazaneen","family":"Grant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Schlegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pvr.2019.100181_bib1","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/archotol.125.7.743","article-title":"Initial results from the national registry for juvenile-onset recurrent respiratory papillomatosis. RRP Task Force","volume":"125","author":"Armstrong","year":"1999","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.pvr.2019.100181_bib2","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.rmed.2017.03.030","article-title":"Recurrent respiratory papillomatosis: a state-of-the-art review","volume":"126","author":"Fortes","year":"2017","journal-title":"Respir. Med."},{"key":"10.1016\/j.pvr.2019.100181_bib3","first-page":"481","article-title":"Recurrent respiratory papillomatosis (RRP)-Juvenile onset","volume":"2","author":"Dyrstad","year":"2008","journal-title":"Clin. Med. Oncol."},{"key":"10.1016\/j.pvr.2019.100181_bib4","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1001\/archotol.1995.01890120044008","article-title":"Task force on recurrent respiratory papillomas: a preliminary report","volume":"121","author":"Derkay","year":"1995","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.pvr.2019.100181_bib5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00405-007-0546-z","article-title":"Recurrent respiratory papillomatosis: an overview of current thinking and treatment","volume":"265","author":"Goon","year":"2008","journal-title":"Eur. Arch. Oto-Rhino-Laryngol."},{"key":"10.1016\/j.pvr.2019.100181_bib6","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1097\/MLG.0b013e31816a7135","article-title":"Recurrent respiratory papillomatosis: a review","volume":"118","author":"Derkay","year":"2008","journal-title":"The Laryngoscope"},{"key":"10.1016\/j.pvr.2019.100181_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/lary.24602","article-title":"Genetic dysregulation in recurrent respiratory papillomatosis","author":"Rodman","year":"2014","journal-title":"The Laryngoscope"},{"key":"10.1016\/j.pvr.2019.100181_bib8","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ajpath.2011.10.036","article-title":"ROCK inhibitor and feeder cells induce the conditional reprogramming of epithelial cells","volume":"180","author":"Liu","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.pvr.2019.100181_bib9","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nprot.2016.174","article-title":"Conditional reprogramming and long-term expansion of normal and tumor cells from human biospecimens","volume":"12","author":"Liu","year":"2017","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.pvr.2019.100181_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186190","article-title":"Genomic comparison of early-passage conditionally reprogrammed breast cancer cells to their corresponding primary tumors","volume":"12","author":"Mahajan","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.pvr.2019.100181_bib11","doi-asserted-by":"crossref","first-page":"20035","DOI":"10.1073\/pnas.1213241109","article-title":"Conditionally reprogrammed cells represent a stem-like state of adult epithelial cells","volume":"109","author":"Suprynowicz","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.pvr.2019.100181_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-22427-1","article-title":"Patient-derived conditionally reprogrammed cells maintain intra-tumor genetic heterogeneity","volume":"8","author":"Correa","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pvr.2019.100181_bib13","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1056\/NEJMoa1203055","article-title":"Use of reprogrammed cells to identify therapy for respiratory papillomatosis","volume":"367","author":"Yuan","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pvr.2019.100181_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2009.03.019","article-title":"Low-risk human papillomavirus type 6 DNA load and integration in cervical samples from women with squamous intraepithelial lesions","author":"Coutl\u00e9e","year":"2009","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.pvr.2019.100181_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057207","article-title":"Integration of HPV6 and downregulation of AKR1C3 expression mark malignant transformation in a patient with juvenile-onset laryngeal papillomatosis","author":"Huebbers","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pvr.2019.100181_bib16","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1158\/1535-7163.MCT-15-0511","article-title":"Identification of novel ezrin inhibitors targeting metastatic osteosarcoma by screening open access malaria box","volume":"14","author":"Celik","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.pvr.2019.100181_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001862","article-title":"The NCGC pharmaceutical collection: a comprehensive resource of clinically approved drugs enabling repurposing and chemical genomics","volume":"3","author":"Huang","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.pvr.2019.100181_bib18","doi-asserted-by":"crossref","first-page":"7301","DOI":"10.1158\/1078-0432.CCR-17-1121","article-title":"Matrix screen identifies synergistic combination of PARP inhibitors and nicotinamide phosphoribosyltransferase (NAMPT) inhibitors in Ewing sarcoma","volume":"23","author":"Heske","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.pvr.2019.100181_bib19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2217\/fvl.10.73","article-title":"HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress","volume":"6","author":"Williams","year":"2011","journal-title":"Future Virol."},{"key":"10.1016\/j.pvr.2019.100181_bib20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2443.2010.01458.x","article-title":"Rolling circle replication of human papillomavirus type 16 DNA in epithelial cell extracts","volume":"16","author":"Kusumoto-Matsuo","year":"2011","journal-title":"Genes Cells"},{"key":"10.1016\/j.pvr.2019.100181_bib21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10555-008-9166-3","article-title":"The cytoskeleton and cancer","volume":"28","author":"Hall","year":"2009","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.pvr.2019.100181_bib22","doi-asserted-by":"crossref","first-page":"11473","DOI":"10.1073\/pnas.0604348103","article-title":"Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries","volume":"103","author":"Inglese","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.pvr.2019.100181_bib23","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nprot.2008.226","article-title":"Spheroid-based drug screen: considerations and practical approach","volume":"4","author":"Friedrich","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.pvr.2019.100181_bib24","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.eururo.2016.04.019","article-title":"Comprehensive drug testing of patient-derived conditionally reprogrammed cells from castration-resistant prostate cancer","volume":"71","author":"Saeed","year":"2017","journal-title":"Eur. Urol."},{"key":"10.1016\/j.pvr.2019.100181_bib25","article-title":"A multiplex preclinical model for adenoid cystic carcinoma of the salivary gland identifies regorafenib as a potential therapeutic drug","volume":"7","author":"Chen","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pvr.2019.100181_bib26","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.031716","article-title":"Expanding primary cells from mucoepidermoid and other salivary gland neoplasms for genetic and chemosensitivity testing","volume":"11","author":"Alamri","year":"2018","journal-title":"Dis. Model.Mech."},{"key":"10.1016\/j.pvr.2019.100181_bib27","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.pvr.2019.100181_bib28","doi-asserted-by":"crossref","DOI":"10.1186\/gm326","article-title":"Drug repositioning for personalized medicine","volume":"4","author":"Li","year":"2012","journal-title":"Genome Med."},{"author":"U.S.F.","key":"10.1016\/j.pvr.2019.100181_bib29"},{"key":"10.1016\/j.pvr.2019.100181_bib30","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/ja.2011.35","article-title":"Romidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide): a natural product recently approved for cutaneous T-cell lymphoma","volume":"64","author":"Vandermolen","year":"2011","journal-title":"J. Antibiot."},{"key":"10.1016\/j.pvr.2019.100181_bib31","first-page":"225","article-title":"A phase I study of panobinostat in combination with gemcitabine in the treatment of solid tumors","volume":"9","author":"Jones","year":"2011","journal-title":"Clin. Adv. Hematol. Oncol.: HO (Hum. Organ.)"},{"key":"10.1016\/j.pvr.2019.100181_bib32","first-page":"1","article-title":"The safety, efficacy and therapeutic potential of histone deacetylase inhibitors with special reference to panobinostat in gastrointestinal tumors: a review of preclinical and clinical studies","author":"Singh","year":"2017","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.pvr.2019.100181_bib33","doi-asserted-by":"crossref","first-page":"E11138","DOI":"10.1073\/pnas.1801156115","article-title":"Vorinostat, a pan-HDAC inhibitor, abrogates productive HPV-18 DNA amplification","volume":"115","author":"Banerjee","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.pvr.2019.100181_bib34","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1038\/leu.2012.144","article-title":"The novel cyclin-dependent kinase inhibitor dinaciclib (SCH727965) promotes apoptosis and abrogates microenvironmental cytokine protection in chronic lymphocytic leukemia cells","volume":"26","author":"Johnson","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.pvr.2019.100181_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059588","article-title":"The anti-melanoma activity of dinaciclib, a cyclin-dependent kinase inhibitor, is dependent on p53 signaling","volume":"8","author":"Desai","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pvr.2019.100181_bib36","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1158\/1535-7163.MCT-11-0167","article-title":"The cyclin-dependent kinase inhibitor SCH 727965 (dinacliclib) induces the apoptosis of osteosarcoma cells","volume":"10","author":"Fu","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.pvr.2019.100181_bib37","doi-asserted-by":"crossref","first-page":"598","DOI":"10.4161\/cbt.12.7.16475","article-title":"Cyclin-dependent kinase inhibitor dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft models","volume":"12","author":"Feldmann","year":"2011","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.pvr.2019.100181_bib38","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1158\/1078-0432.CCR-09-0787","article-title":"Targeting the RB-pathway in cancer therapy","volume":"16","author":"Knudsen","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.pvr.2019.100181_bib39","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pharmthera.2017.02.008","article-title":"Inhibitors of cyclin-dependent kinases as cancer therapeutics","volume":"173","author":"Whittaker","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.pvr.2019.100181_bib40","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/sj.leu.2402535","article-title":"Synergistic induction of mitochondrial damage and apoptosis in human leukemia cells by flavopiridol and the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA)","volume":"16","author":"Almenara","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.pvr.2019.100181_bib41","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.23485","article-title":"Combined inhibition of CDK and HDAC as a promising therapeutic strategy for both cutaneous and uveal metastatic melanoma","volume":"9","author":"Heijkants","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.pvr.2019.100181_bib42","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1080\/1028602042000204135","article-title":"Two new diterpenoids from coleus forskohlii","volume":"7","author":"Shen","year":"2005","journal-title":"J. Asian Nat. Prod. Res."},{"key":"10.1016\/j.pvr.2019.100181_bib43","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/oby.2005.162","article-title":"Body composition and hormonal adaptations associated with forskolin consumption in overweight and obese men","volume":"13","author":"Godard","year":"2005","journal-title":"Obes. Res."},{"key":"10.1016\/j.pvr.2019.100181_bib44","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1177\/147323000603400210","article-title":"Forskolin versus sodium cromoglycate for prevention of asthma attacks: a single-blinded clinical trial","volume":"34","author":"Gonz\u00e1lez-S\u00e1nchez","year":"2006","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.pvr.2019.100181_bib45","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.sjopt.2015.02.003","article-title":"Efficacy and safety of 1% forskolin eye drops in open angle glaucoma - an open label study","volume":"29","author":"Majeed","year":"2015","journal-title":"Saudi.Journal of Ophthalmology"},{"key":"10.1016\/j.pvr.2019.100181_bib46","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/ijc.2910320622","article-title":"Forskolin: a potential antimetastatic agent","volume":"32","author":"Agarwal","year":"1983","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.pvr.2019.100181_bib47","doi-asserted-by":"crossref","first-page":"5248","DOI":"10.1158\/0008-5472.CAN-07-0097","article-title":"Chemoresistant KM12C colon cancer cells are addicted to low cyclic AMP levels in a phosphodiesterase 4-regulated compartment via effects on phosphoinositide 3-kinase","volume":"67","author":"McEwan","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.pvr.2019.100181_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.360","article-title":"Large-scale pharmacological profiling of 3D tumor models of cancer cells","volume":"7","author":"Mathews Griner","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.pvr.2019.100181_bib49","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0042-6822(92)90068-Z","article-title":"Replication and persistence of HPV DNA in cultured cells derived from laryngeal papillomas","volume":"186","author":"DiLorenzo","year":"1992","journal-title":"Virology"}],"container-title":["Papillomavirus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405852118300478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405852118300478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T11:04:49Z","timestamp":1762513489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405852118300478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":49,"alternative-id":["S2405852118300478"],"URL":"https:\/\/doi.org\/10.1016\/j.pvr.2019.100181","relation":{},"ISSN":["2405-8521"],"issn-type":[{"type":"print","value":"2405-8521"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-throughput screening identifies candidate drugs for the treatment of recurrent respiratory papillomatosis","name":"articletitle","label":"Article Title"},{"value":"Papillomavirus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pvr.2019.100181","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100181"}}